PMID- 25464018 OWN - NLM STAT- MEDLINE DCOM- 20151008 LR - 20151119 IS - 1873-2933 (Electronic) IS - 0009-9120 (Linking) VI - 48 IP - 3 DP - 2015 Feb TI - Methodological considerations to determine the effect of exercise on brain-derived neurotrophic factor levels. PG - 162-6 LID - S0009-9120(14)00772-3 [pii] LID - 10.1016/j.clinbiochem.2014.11.013 [doi] AB - OBJECTIVES: Physical exercise up-regulates brain-derived neurotrophic factor (BDNF) in the brain and blood. However, there is yet no consensus about the adequate blood processing conditions to standardize its assessment. We aimed to find a reliable blood sample processing method to determine changes in BDNF due to exercise. DESIGN AND METHODS: Twelve healthy university students performed an incremental cycling test to exhaustion. At baseline, immediately after exercise, and 30 and 60 min of recovery, venous blood was drawn and processed under different conditions, i.e. whole blood, serum coagulated for 10 min and 24 h, total plasma, and platelet-free plasma. BDNF concentration was measured by ELISA. RESULTS: Exercise increased BDNF in whole blood and in serum coagulated for 24 h when corrected by hemoconcentration. We did not find effects of exercise on BDNF in serum coagulated for 10 min or in plasma samples. Plasma shows heterogeneous BDNF values in response to exercise that are not prevented when platelets are eliminated while homogeneous BDNF levels were found in whole blood or serum coagulated for 24 hour samples. CONCLUSIONS: In exercise studies, BDNF levels should be adjusted by hemoconcentration. Our data highlight the importance of blood sample selection since the differences between each one affect significantly the BDNF factor changes due to exercise. CI - Copyright (c) 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved. FAU - Pareja-Galeano, Helios AU - Pareja-Galeano H AD - Department of Physiology, School of Medicine, University of Valencia, INCLIVA, Valencia, Spain. Electronic address: helios.pareja@gmail.com. FAU - Alis, Rafael AU - Alis R AD - School of Medicine and Research Institute "Dr. Vina Giner", Molecular and Mitochondrial Medicine, Catholic University of Valencia San Vicente Martir, Valencia, Spain. FAU - Sanchis-Gomar, Fabian AU - Sanchis-Gomar F AD - Department of Physiology, School of Medicine, University of Valencia, INCLIVA, Valencia, Spain. FAU - Cabo, Helena AU - Cabo H AD - Department of Physiology, School of Medicine, University of Valencia, INCLIVA, Valencia, Spain. FAU - Cortell-Ballester, Jose AU - Cortell-Ballester J AD - Hospital La Fe., Valencia, Spain. FAU - Gomez-Cabrera, Mari Carmen AU - Gomez-Cabrera MC AD - Department of Physiology, School of Medicine, University of Valencia, INCLIVA, Valencia, Spain. FAU - Lucia, Alejandro AU - Lucia A AD - European University, Madrid, Spain; Research Institute of Hospital 12 de Octubre ('i+12'), Madrid, Spain. FAU - Vina, Jose AU - Vina J AD - Department of Physiology, School of Medicine, University of Valencia, INCLIVA, Valencia, Spain. LA - eng PT - Clinical Trial PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20141121 PL - United States TA - Clin Biochem JT - Clinical biochemistry JID - 0133660 RN - 0 (Brain-Derived Neurotrophic Factor) SB - IM MH - Adult MH - Blood Specimen Collection/*methods MH - Brain-Derived Neurotrophic Factor/*blood MH - Energy Metabolism MH - Exercise/*physiology MH - Humans MH - Male MH - Serum/metabolism MH - Surveys and Questionnaires OTO - NOTNLM OT - Enzyme-linked immunosorbent assay OT - Hemoconcentration OT - Plasma OT - Serum OT - Whole blood EDAT- 2014/12/03 06:00 MHDA- 2015/10/09 06:00 CRDT- 2014/12/03 06:00 PHST- 2014/10/02 00:00 [received] PHST- 2014/11/09 00:00 [revised] PHST- 2014/11/11 00:00 [accepted] PHST- 2014/12/03 06:00 [entrez] PHST- 2014/12/03 06:00 [pubmed] PHST- 2015/10/09 06:00 [medline] AID - S0009-9120(14)00772-3 [pii] AID - 10.1016/j.clinbiochem.2014.11.013 [doi] PST - ppublish SO - Clin Biochem. 2015 Feb;48(3):162-6. doi: 10.1016/j.clinbiochem.2014.11.013. Epub 2014 Nov 21.